Market Currents
AbbVie (ABBV) is suing Indian generic drugmaker Sun Pharmaceutical for infringing on its patent...
-
Friday, January 25, 6:19 PM ETAbbVie (ABBV) is suing Indian generic drugmaker Sun Pharmaceutical for infringing on its patent for Zemplar, a drug used to treat secondary hyperparathyroidism in people with chronic kidney failure. The company asserts that Mumbai-based Sun is preparing to market a low-cost version of the drug prior to its U.S. patent expiry in 2016. View the complaint in its entirety here.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
This news story has 1 comment:
Granted there are those who MUST, and can't afford anything else. For them, I would ask ABBieVie to make an exception in cost, not have the poor accept less. The poor should not have to accept less because they aren't wealthy.